Q1 2023 Holdings
Filed 2023-05-15 | 117 holdings | $440.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Sarepta Therapeutics Inc(SRPT)Put | COM | 803607100 | $37.4M | 271,300 | 8.5% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $28.3M | 205,400 | 6.4% |
| Intra-Cellular Therapies Inc(ITCIEUR)Call | COM | 46116X101 | $20.6M | 380,000 | 4.7% |
| Prometheus Biosciences Inc | COM | 74349U108 | $13.5M | 125,926 | 3.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $12.0M | 774,398 | 2.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $11.6M | 869,390 | 2.6% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $10.6M | 100,000 | 2.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $9.9M | 594,686 | 2.2% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $9.3M | 150,000 | 2.1% |
| Axsome Therapeutics Inc(AXSM)Put | COM | 05464T104 | $9.3M | 150,000 | 2.1% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $9.1M | 549,600 | 2.1% |
| Reata Pharmaceuticals Inc(RETAEUR)Call | CL A | 75615P103 | $9.1M | 100,000 | 2.1% |
| Biomea Fusion Inc(BMEA)Call | COM | 09077A106 | $9.0M | 291,000 | 2.0% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $8.5M | 721,341 | 1.9% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $8.4M | 225,000 | 1.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.3M | 485,000 | 1.9% |
| Morphic Hldg IncCall | COM | 61775R105 | $8.0M | 213,400 | 1.8% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $7.6M | 100,000 | 1.7% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $7.3M | 80,564 | 1.7% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.6M | 100,000 | 1.5% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $6.6M | 283,464 | 1.5% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $6.5M | 210,975 | 1.5% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $6.4M | 885,334 | 1.4% |
| Aclaris Therapeutics Inc(ACRS)Put | COM | 00461U105 | $5.9M | 732,000 | 1.3% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $5.7M | 160,486 | 1.3% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $5.5M | 402,326 | 1.2% |
| Tracon Pharmaceuticals Inc | COM NEW | 89237H209 | $5.2M | 2,765,530 | 1.2% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $5.2M | 213,521 | 1.2% |
| Protagonist Therapeutics Inc(PTGX)Put | COM | 74366E102 | $4.9M | 211,400 | 1.1% |
| Protagonist Therapeutics Inc(PTGX)Call | COM | 74366E102 | $4.9M | 211,400 | 1.1% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.9M | 50,000 | 1.1% |
| Aclaris Therapeutics Inc(ACRS)Call | COM | 00461U105 | $4.8M | 589,300 | 1.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $4.6M | 228,677 | 1.0% |
| Altimmune Inc(ALT)Put | COM NEW | 02155H200 | $4.5M | 1,077,200 | 1.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $4.4M | 207,112 | 1.0% |
| Amylyx Pharmaceuticals Inc(AMLX)Call | COM | 03237H101 | $4.4M | 150,000 | 1.0% |
| Bicycle Therapeutics PLC(BCYC)Call | SPONSORED ADS | 088786108 | $4.3M | 200,000 | 1.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $4.2M | 575,000 | 1.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.2M | 230,000 | 1.0% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $4.0M | 110,000 | 0.9% |
| Aerovate Therapeutics Inc | COM | 008064107 | $3.9M | 195,146 | 0.9% |
| Merus N V | COM | N5749R100 | $3.8M | 208,650 | 0.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $3.8M | 106,057 | 0.9% |
| Altimmune Inc(ALT)Call | COM NEW | 02155H200 | $3.8M | 898,600 | 0.9% |
| Select Sector Spdr TR(XLV) | SBI HEALTHCARE | 81369Y209 | $3.6M | 27,469 | 0.8% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $3.4M | 200,000 | 0.8% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.9M | 677,300 | 0.6% |
| Biovie Inc | CL A NEW | 09074F207 | $2.8M | 348,556 | 0.6% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $2.8M | 578,825 | 0.6% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $2.7M | 174,510 | 0.6% |